Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Immune system response modulation" refers to strategies and interventions aimed at altering the activity of the immune system to achieve therapeutic benefit. This can involve enhancing an underactive immune response (as in cancer immunotherapy) or suppressing an overactive one (as in autoimmune diseases). Approaches include manipulating cytokines and chemokines; targeting co-stimulatory molecules such as CD40/CD40L; using monoclonal antibodies against checkpoints; modifying cellular metabolism; and employing gene editing tools. These interventions act on various molecular targets within complex networks that regulate immunity but do not represent a single molecule or receptor themselves. Therefore, "immune system response modulation" is not considered a canonical therapeutic target but rather describes a class of therapeutic strategies involving multiple distinct molecular entities across diverse biological pathways.[1][2][3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system response modulation.